Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (241-250 of 374) with videos related to

Pageof 38
Sort By:
Cancers|September 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid NeoplasmsSimone Thomas, Martin Wermke, Vladan Vučinić, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2011
Purinergic receptor type 6 contributes to airway inflammation and remodeling in experimental allergic airway inflammationRodolfo Paula Vieira, Tobias Müller, Melanie Grimm, et al.
Bone Marrow Transplantation|May 26, 2026
The 2026 definition of ruxolitinib refractoriness in severe acute GVHDFlorent Malard, Yi Bin Chen, Monzr M Al Malki, et al.
Blood|January 19, 2013
Inflammatory neovascularization during graft-versus-host disease is regulated by αv integrin and miR-100Franziska Leonhardt, Sebastian Grundmann, Martin Behe, et al.
Leukemia|March 24, 2020
Existence of reprogrammed lymphoma stem cells in a murine ALCL-like modelStefanie Kreutmair, Cathrin Klingeberg, Teresa Poggio, et al.
Bone Marrow Transplantation|April 14, 2025
Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter surveyNiklas Brehm, Francesca Biavasco, Johannes Clausen, et al.
Leukemia|March 28, 2024
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
The Journal of Clinical Investigation|October 21, 2014
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemiaNiuscha Yaktapour, Frank Meiss, Justin Mastroianni, et al.
Oncoimmunology|May 8, 2015
Identification and characterization of the specific murine NK cell subset supporting graft-<i>versus</i>-leukemia- and reducing graft-<i>versus</i>-host-effectsKathrin Meinhardt, Irena Kroeger, Ruth Bauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysemaSanja Cicko, Monica Lucattelli, Tobias Müller, et al.
Pageof 38

Showing results (241-250 of 374) with videos related to

Sort By:
Pageof 38
Cancers|September 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid NeoplasmsSimone Thomas, Martin Wermke, Vladan Vučinić, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2011
Purinergic receptor type 6 contributes to airway inflammation and remodeling in experimental allergic airway inflammationRodolfo Paula Vieira, Tobias Müller, Melanie Grimm, et al.
Bone Marrow Transplantation|May 26, 2026
The 2026 definition of ruxolitinib refractoriness in severe acute GVHDFlorent Malard, Yi Bin Chen, Monzr M Al Malki, et al.
Blood|January 19, 2013
Inflammatory neovascularization during graft-versus-host disease is regulated by αv integrin and miR-100Franziska Leonhardt, Sebastian Grundmann, Martin Behe, et al.
Leukemia|March 24, 2020
Existence of reprogrammed lymphoma stem cells in a murine ALCL-like modelStefanie Kreutmair, Cathrin Klingeberg, Teresa Poggio, et al.
Bone Marrow Transplantation|April 14, 2025
Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter surveyNiklas Brehm, Francesca Biavasco, Johannes Clausen, et al.
Leukemia|March 28, 2024
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
The Journal of Clinical Investigation|October 21, 2014
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemiaNiuscha Yaktapour, Frank Meiss, Justin Mastroianni, et al.
Oncoimmunology|May 8, 2015
Identification and characterization of the specific murine NK cell subset supporting graft-<i>versus</i>-leukemia- and reducing graft-<i>versus</i>-host-effectsKathrin Meinhardt, Irena Kroeger, Ruth Bauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysemaSanja Cicko, Monica Lucattelli, Tobias Müller, et al.
Pageof 38